2016
DOI: 10.1165/rcmb.2015-0358oc
|View full text |Cite
|
Sign up to set email alerts
|

Pathological Hyaluronan Matrices in Cystic Fibrosis Airways and Secretions

Abstract: Hyaluronan (HA) has been used in treatment of cystic fibrosis (CF) via a nebulizer and has demonstrated success in clinical outcomes. HA is an important glycosaminoglycan that is cross-linked by heavy chains (HCs) from inter-α-inhibitor during inflammation. HC cross-linked HA (HC-HA) becomes significantly more adhesive for leukocytes than non-cross-linked HA, which can enhance inflammation. Our studies tested the hypothesis that HC-HA is present in CF airways and that altered ratios of HC-HA to its degradation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
23
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 24 publications
(26 citation statements)
references
References 34 publications
3
23
0
Order By: Relevance
“…HC-modified HA is prominently featured in the extracellular matrix of chronic lung diseases such as pulmonary arterial hypertension [ 11 ], asthma [ 12 ], cystic fibrosis [ 13 ], and idiopathic pulmonary fibrosis [ 14 ], that share lung inflammation in their pathogenesis, suggesting that HC-HA formation is important in either promoting the onset or delaying the resolution of lung inflammation. We therefore used self-resolving models of ALI that were induced by intratracheal instillation of LPS or gram negative bacteria Pseudomonas aeruginosa (PA) to study the kinetics and role of HC-modified HA in acute lung inflammation.…”
Section: Introductionmentioning
confidence: 99%
“…HC-modified HA is prominently featured in the extracellular matrix of chronic lung diseases such as pulmonary arterial hypertension [ 11 ], asthma [ 12 ], cystic fibrosis [ 13 ], and idiopathic pulmonary fibrosis [ 14 ], that share lung inflammation in their pathogenesis, suggesting that HC-HA formation is important in either promoting the onset or delaying the resolution of lung inflammation. We therefore used self-resolving models of ALI that were induced by intratracheal instillation of LPS or gram negative bacteria Pseudomonas aeruginosa (PA) to study the kinetics and role of HC-modified HA in acute lung inflammation.…”
Section: Introductionmentioning
confidence: 99%
“…There are several methods to monitor shifts in hyaluronan in tissue. FACE technology is useful in complex tissues since it allows for semi-quantification of total HA, as well as the strunctural identiy of the HA regarding the change in TSG-6 mediated glycosylation and HA converting from low molecular weight to high molecular forms which are pathogenic [ 29 , 30 ]. HSAE technology, however, is able to qualitatively detect differences in size to distinguish high molecular weight vs. low molecular weight hyaluronan.…”
Section: Resultsmentioning
confidence: 99%
“…To determine the state and quantity of HA, lung homogenates were processed using FACE [ 29 ]. The process involves isolating and breaking down the HA into its component disaccharides which are fluorescently labeled and then processed with gel electrophoresis and digital imaging.…”
Section: Methodsmentioning
confidence: 99%
“…The formation of extracellular or cell surface ITIH-HA complexes promotes the adhesion of leukocytes [ 60 ]. It could be ascertained that expression of ITIH-5 within cerebral endothelium could promote the adhesion and extravasation of circulating leukocytes through the damaged cerebral vasculature, suggesting a potential detrimental role [ 20 , 63 ]. Yet, treatment with human ITI for inflammatory syndromes such as endotoxin shock has been shown to confer therapeutic effects, indicating its potential anti-inflammatory roles [ 64 ].…”
Section: Discussionmentioning
confidence: 99%